指南与共识乳腺MR乳腺X线US

遗传性乳腺癌患者的基因检测与筛查建议

Genetic Testing and Screening Recommendations for Patients with Hereditary Breast Cancer.
指南 / 共识 · Radiographics · 2020-05-29

本文综述遗传咨询流程及高风险与中度风险患者的筛查建议,讨论Gail和Tyrer-Cuzick等风险评估工具,并回顾BRCA1/BRCA2、TP53、PTEN、CDH1、STK11等高危基因及ATM、CHEK2、PALB2等中度风险基因相关乳腺癌的影像表现及其他相关癌症。

要点

  • 乳腺影像专科医师可能最先与绝经前乳腺癌或乳腺癌/卵巢癌家族史患者开启遗传咨询对话。
  • 放射科医师应能提供咨询并识别需转诊进行基因检测的患者。
  • 基因检测结果有助于实现针对患者的适当筛查,通过早期发现和及时治疗改善总生存。

核心结论

  • 基因检测结果最终能够实现针对患者的适当筛查,从而通过早期发现和及时治疗改善总生存。
  • 放射科医师应能够提供咨询并识别应转诊进行基因检测的患者。

研究设计与样本

  • 本文为综述,讨论遗传咨询流程及高风险与中度风险患者的筛查建议。
  • 文中涉及Gail和Tyrer-Cuzick等乳腺癌风险评估工具用于检测前咨询。

关键影像表现/征象

  • 文中描述了与每种基因突变通常相关的乳腺癌影像表现及其他相关癌症。

诊断标准与关键数值

  • 与乳腺癌相关的最常见高风险基因突变包括BRCA1、BRCA2、TP53、PTEN、CDH1和STK11。
  • 中度风险基因包括ATM、CHEK2和PALB2。

临床应用与阅片要点

  • 乳腺影像专科医师可能最先与绝经前乳腺癌诊断或乳腺癌/卵巢癌家族史强烈的患者开启遗传咨询对话。
  • 放射科医师应能够提供咨询并识别应转诊进行基因检测的患者。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Professionals who specialize in breast imaging may be the first to initiate the conversation about genetic counseling with patients who have a diagnosis of premenopausal breast cancer or a strong family history of breast and ovarian cancer. Commercial genetic testing panels have gained popularity and have become more affordable in recent years. Therefore, it is imperative for radiologists to be able to provide counseling and to identify those patients who should be referred for genetic testing. The authors review the process of genetic counseling and the associated screening recommendations for patients at high and moderate risk. Ultimately, genetic test results enable appropriate patient-specific screening, which allows improvement of overall survival by early detection and timely treatment. The authors discuss pretest counseling, which involves the use of various breast cancer risk assessment tools such as the Gail and Tyrer-Cuzick models. The most common high- and moderate-risk gene mutations associated with breast cancer are also reviewed. In addition to BRCA1 and BRCA2, several high-risk genes, including TP53, PTEN, CDH1, and STK11, are discussed. Moderate-risk genes include ATM, CHEK2, and PALB2. The imaging appearances of breast cancer typically associated with each gene mutation, as well as the other associated cancers, are described. ©RSNA, 2020 See discussion on this article by Butler (pp 937-940).

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Bharucha PP, Chiu KE, François FM, et al. Genetic Testing and Screening Recommendations for Patients with Hereditary Breast Cancer. Radiographics. 2020. PMID: 32469631. doi:10.1148/rg.2020190181

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。